Expression profiling and pharmacotherapeutic development in the central nervous system

Alzheimer Disease and Associated Disorders

Volumn 18, Issue 4, 2004, Pages 264-269

  Galvin, James E ^a,d   Ginsberg, Stephen D ^b,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Alzheimer Disease Research Center   (United States)

Author keywords

And single cell analysis; CDNA microarray; Dementia; Pharmacogenomics; Postmortem human brain; RNA amplification

Indexed keywords

CELL DIFFERENTIATION; CELL MATURATION; CENTRAL NERVOUS SYSTEM; DEMENTIA; DNA FINGERPRINTING; DNA MICROARRAY; GENE AMPLIFICATION; MUTATION; PATHOGENESIS; PHARMACOGENOMICS; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

CENTRAL NERVOUS SYSTEM; GENE EXPRESSION PROFILING; HUMANS; NEURODEGENERATIVE DISEASES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TECHNOLOGY, PHARMACEUTICAL;

EID: 11344254769     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (77)

1. Galvin JE, Lee VM-Y, Trojanowski JQ. Synucleinopathies: clinical and pathological implications. Arch Neurol. 2000;58:186-190.
2. Goedert M. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies. Phil Trans R Soc Lond B Bioi Sci. 1999;354:1101-1118.
3. Trojanowski JQ, Mattson MP. Overview of protein aggregation in single, double, and triple neurodegenerative brain amyloidoses. Neuromolecular Med. 2003;4:1-6.
4. Duggan DJ, Bittner M, Chen Y, et al. Expression profiling using cDNA microarrays. Nat Genet. 1999;21(suppl):10-14.
5. Eberwine J, Yeh H, Miyashiro K. Analysis of gene expression in single live neurons. Proc Natl Acad Sci USA. 1992;89:3010-3014.
6. Eberwine J, Crino PB, Dichter M. Single-cell mRNA amplification: implications for basic and clinical neuroscience. Neuroscientist. 1995;1:200-211.
7. Ginsberg SD, Crino PB, Hemby SE, et al. Predominance of neuronal mRNAs in individual Alzheimer's disease senile plaques. Ann Neurol. 1999;45:174-181.
8. Brown PO, Botstein D. Exploring the new world of the genome with DNA microarrays. Nat Genet. 1999;21(suppl):33-37.
9. Eisen MB, Brown PO. DNA arrays for analysis of gene expression. Methods Enzymol. 1999;303:179-205.
10. Lockhart DJ, Dong H, Byrne MC, et al. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol. 1996;14:1675-1680.
11. Eberwine J, Kacharmina JE, Andrews C, et al. mRNA expression analysis of tissue sections and single cells. J Neurosci. 2001;21:8310-8314.
12. Ginsberg SD, Schmidt ML, Crino PB, et al. Molecular pathology of Alzheimer's disease and related disorders. In: Peters A, Morrison JH, eds. Cerebral Cortex, vol. 14. Neurodegenerative and Age-Related Changes in Structure and Function of Cerebral Cortex. New York: Kluwer Academic/Plenum, 1999:603-653.
13. Ginsberg SD, Che S. RNA amplification in brain tissues. Neurochem Res. 2002;27:981-992.
14. Hemby SE, Trojanowski JQ, Ginsberg SD. Neuron-specific age-related decreases in dopamine receptor subtype mRNAs. J Comp Neurol. 2003;456:176-183.
15. Kacharmina JE, Crino PB, Eberwine J. Preparation of cDNA from single cells and subcellular regions. Methods Enzymol. 1999;303:3-18.
16. Ginsberg SD, Elarova I, Ruben M, et al. Single cell gene expression analysis: implications for neurodegenerative and neuropsychiatric disorders. Neurochem Res. 2004;29:1054-1065.
17. Ginsberg SD. Gene expression profiling using single cell microdissection combined with cDNA microarrays. In: Geschwind DH, ed. DNA Microarrays: The New Frontier in Gene Discovery and Gene Expression Analysis. Washington, DC: Society for Neuroscience Press, 2001:61-70.
18. Mirnics K, Middleton FA, Marquez A, et al. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron. 2000;28:53-67.
19. Hakak Y, Walker JR, Li C, et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA. 2001;98:4746-4751.
20. Crino PB, Khodakhah K, Becker K, et al. Presence and phosphorylation of transcription factors in dendrites. Proc Natl Acad Sci USA. 1998;95:2313-2318.
21. Ginsberg SD, Che S. Combined histochemical staining, RNA amplification, and cDNA array analysis within the hippocampus. Lab Invest. In press.
22. Hemby SE, Ginsberg SD, Brunk B, et al. Gene expression profile for schizophrenia: discrete neuron transcription patterns in the entorhinal cortex. Arch Gen Psychiatry. 2002;59:631-640.
23. Mufson EJ, Counts SE, Ginsberg SD. Single cell gene expression profiles of nucleus basalis cholinergic neurons in Alzheimer's disease. Neurochem Res. 2002;27:1035-1048.
24. Kotlyar M, Fuhrman S, Ableson A, et al. Spearman correlation identifies statistically significant gene expression clusters in spinal cord development and injury. Neurochem Res. 2002;27:1133-1140.
25. Dixon AK, Lee K, Richardson PJ, et al. Single cell expression analysis: pharmacogenomic potential. Pharmacogenomics. 2002;3:809-822.
26. Freeman TC, Lee K, Richardson PJ. Analysis of gene expression in single cells. Curr Opin Biotechnol. 1999;10:579-582.
27. Colantuoni C, Purcell AE, Bouton CM, et al. High throughput analysis of gene expression in the human brain. J Neurosci Res. 2000;59:1-10.
28. Lockhart DJ, Barlow C. Expressing what's on your mind: DNA arrays and the brain. Nat Rev Neurosci. 2001;2:63-68.
29. Serafini T. Of neurons and gene chips. Curr Opin Neurobiol. 1999;9:641-644.
30. Galvin JE. Neurodegenerative diseases: pathology and the advantage of single cell profiling. Neurochem Res. 2004;29:1041-1051.
31. Karnrne F, Salunga R, Yu J, et al. Single-cell micro array analysis in hippocampus CA: 1. Demonstration and validation of cellular heterogeneity. J Neurosci. 2003;23:3607-3615.
32. Ginsberg SD, Galvin JE, Chiu TS, et al. RNA sequestration to pathological lesions of neurodegenerative disorders. Acta Neuropathol. 1998;96:487-494.
33. Fasulo WH, Hemby SE. Time-dependent changes in gene expression profiles of midbrain dopamine neurons following haloperidol administration. J Neurochem. 2003;87:205-219.
34. Tang WX, Fasulo WH, Mash DC, et al. Molecular profiling of midbrain dopamine regions in cocaine overdose victims. J Neurochem. 2003;85:911-924.
35. Che S, Ginsberg SD. Amplification of transcripts using terminal continuation. Lab Invest. 2004;84:131-137.
36. Weidenharnmer EM, Kahl BF, Wang L, et al. Multiplexed, targeted gene expression profiling and genetic analysis on electronic microarrays. Clin Chem. 2002;48:1873-1882.
37. Blalock EM, Chen KC, Sharrow K, Herman JP, Porter NM, Foster TC, Landfield PW. Gene microarrays in hippocampal aging: statistical profiling identifies novel processes correlated with cognitive impairment. J Neurosci. 2003,23:3807-3819.
38. Sokolov BP, Jiang L, Trivedi NS, Aston C. Transcription profiling reveals mitochondrial, ubiquitin and signaling systems abnormalities in postmortem brains from subjects with a history of alcohol abuse or dependence. J Neurosci Res. 2003;72:756-767.
39. Saito T, Lachman HM, Diaz L, Hallikainen T, Kauhanen J, Salonen JT, Ryynanen OP, Karvonen MK, Syvalahti E, Pohjalainen T, Hietala J, Tiihonen J. Analysis of monoamine oxidase A (MAOA) promoter polymorphism in Finnish male alcoholics. Psychiatry Res. 2002;109:113-119.
40. Colangelo V, Schurr J, Ball MJ, Pelaez RP, Bazan NG, Lukiw WJ. Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J Neurosci Res. 2002;70:462-473.
41. Loring JF, Wen X, Lee JM, Seilhamer J, Somogyi R. A gene expression profile of Alzheimer's disease. DNA Cell Biol. 2001;20:683-695.
42. Dickey CA, Gordon MN, Mason JE, Wilson NJ, Diamond DM, Guzowski JF, Morgan D. Amyloid suppresses induction of genes critical for memory consolidation in APP + PS1 transgenic mice. J Neurochem. 2004;88:434-442.
43. Purcell AE, Jeon OH, Pevsner J. The abnormal regulation of gene expression in autistic brain tissue. JAutism Dev Disord. 2001;31:545-549.
44. Malaspina A, Kaushik N, de Belleroche J. Differential expression of 14 genes in amyotrophic lateral sclerosis spinal cord detected using gridded cDNA arrays. J Neurochem. 2001;77:132-145.
45. Yoshihara T, Ishigaki S, Yamamoto M, Liang Y, Niwa J, Takeuchi H, Doyu M, Sobue G. Differential expression of inflammation- and apoptosis-related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem. 2002;80:158-167.
46. Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, Jones PB, Starkey M, Webster MJ, Yolken RH, Bahn S. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet. 2003;362:798-805.
47. Lehrmann E, Oyler J, Vawter MP, Hyde TM, Kolachana B, Kleinman JE, Huestis MA, Becker KG, Freed WJ. Transcriptional profiling in the human prefrontal cortex: evidence for two activational states associated with cocaine abuse. Pharmacogenomics J. 2003;3:27-40.
48. Freeman WM, Dougherty KE, Vacca SE, Vrana KE. An interactive database of cocaine-responsive gene expression. Scientific World Journal. 2002;2:701-706.
49. Newton SS, Collier EF, Hunsberger J, Adams D, Terwilliger R, Selvanayagam E, Duman RS. Gene profile of electroconvulsive seizures: induction of neurotrophic and angiogenic factors. J Neurosci. 2003;23:10841-10851.
50. Elliott RC, Miles MF, Lowenstein DH. Overlapping microarray profiles of dentate gyrus gene expression during development- and epilepsy-associated neurogenesis and axon outgrowth. J Neurosci. 2003;23:2218-2227.
51. D'Agata V, Warren ST, Zhao W, Torre ER, Alkon DL, Cavallaro S. Gene expression profiles in a transgenic animal model of fragile X syndrome. Neurobiol Dis. 2002;10:211-218.
52. Mariani L, Beaudry C, McDonough WS, Hoelzinger DB, Demuth T, Ross KR, Berens T, Coons SW, Watts G, Trent JM, Wei JS, Giese A, Berens ME. Glioma cell motility is associated with reduced transcription of proapoptotic and proliferation genes: a cDNA microarray analysis. J Neurooncol. 2001;53:161-176.
53. Rickman DS, Bobek MP, Misek DE, Kuick R, Blaivas M, Kumit DM, Taylor J, Hanash SM. Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis. Cancer Res. 2001;61:6885-6891.
54. Gilbert RW, Costain WJ, Blanchard ME, Mullen KL, Currie RW, Robertson HA. DNA microarray analysis of hippocampal gene expression measured twelve hours after hypoxia-ischemia in the mouse. J Cereb Blood Flow Metab. 2003;23:1195-1211.
55. Schmidt-Kastner R, Zhang B, Belayev L, Khoutorova L, Amin R, Busto R, Ginsberg MD. DNA microarray analysis of cortical gene expression during early recirculation after focal brain ischemia in rat. Brain Res Mol Brain Res. 2002;108:81-93.
56. Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, Garren H, Langer-Gould A, Strober S, Cannella B, Allard J, Klonowski P, Austin A, Lad N, Kaminski N, Galli SJ, Oksenberg JR, Raine CS, Heller R, Steinman L. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med. 2002;8:500-508.
57. Mycko MP, Papoian R, Boschert U, Raine CS, Selmaj KW. cDNA microarray analysis in multiple sclerosis lesions: detection of genes associated with disease activity. Brain. 2003;126:1048-1057.
58. Grunblatt E, Mandel S, Maor G, Youdim MB. Gene expression analysis in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice model of Parkinson's disease using cDNA microarray: effect of R-apomorphine. J Neurochem. 2001;78:1-12.
59. Mandel S, Weinreb O, Youdim MB. Using cDNA microarray to assess Parkinson's disease models and the effects of neuroprotective drugs. Trends Pharmacol Sci. 2003;24:184-191.
60. Hakak Y, Walker JR, Li C, Wong WH, Davis KL, Buxbaum JD, Haroutunian V, Fienberg AA. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci U S A. 2001;98:4746-4751.
61. Middleton FA, Mirnics K, Pierri JN, Lewis DA, Levitt P. Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J Neurosci. 2002;22:2718-2729.
62. Mimmack ML, Ryan M, Baba H, Navarro-Ruiz J, Iritani S, Faull RL, McKenna PJ, Jones PB, Arai H, Starkey M, Emson PC, Bahn S. Gene expression analysis in schizophrenia: reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22. Proc Natl Acad Sci U S A. 2002;99:4680-4685.
63. Mirnics K, Middleton FA, Marquez A, Lewis DA, Levitt P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron. 2000;28:53-67,
64. Carmel JB, Galante A, Soteropoulos P, Tolias P, Recce M, Young W, Hart RP. Gene expression profiling of acute spinal cord injury reveals spreading inflammatory signals and neuron loss. Physiol Genomics. 2001;7:201-213.
65. Reyes TM, Walker JR, DeCino C, Hogenesch JB, Sawchenko PE. Categorically distinct acute stressors elicit dissimilar transcriptional profiles in the paraventricular nucleus of the hypothalamus. J Neurosci. 2003;23:5607-5616.
66. Marciano PG, Eberwine JH, Ragupathi R, Saatman KE, Meaney DF, McIntosh TK. Expression profiling following traumatic brain injury: a review. Neurochem Res. 2002;27:1147-1155.
67. Matzilevich DA, Rall JM, Moore AN, Grill RJ, Dash PK. High-density microarray analysis of hippocampal gene expression following experimental brain injury. J Neurosci Res. 2002;67:646-663.
68. Mufson EJ, Counts SE, Ginsberg SD. Gene expression profiles of cholinergic nucleus basalis neurons in Alzheimer's disease. Neurochem Res. 2002;27:1035-1048.
69. Chow N, Cox C, Callahan LM, Weimer JM, Guo L, Coleman PD. Expression profiles of multiple genes in single neurons of Alzheimer's disease. Proc Natl Acad Sci U S A. 1998;95:9620-9625.
70. Ginsberg SD, Hemby SE, Lee VM-Y, et al. Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons. Ann Neurol. 2000;48:77-87.
71. Ginsberg SD, Crino PB, Hemby SE, Weingarten JA, Lee VM, Eberwine JH, Trojanowski JQ. Predominance of neuronal mRNAs in individual Alzheimer's disease senile plaques. Ann Neurol. 1999;45:174-181.
72. Luo ZD, Chaplan SR, Scott BP, Cizkova D, Calcutt NA, Yaksh TL. Neuronal nitric oxide synthase mRNA upregulation in rat sensory neurons after spinal nerve ligation: lack of a role in allodynia development. J Neurosci. 1999;19:9201-9208.
73. Kamme F, Salunga R, Yu J, et al. Single-cell microarray analysis in hippocampus CA1: demonstration and validation of cellular heterogeneity. J Neurosci. 2003;23:3607-3615.
74. Ghasemzadeh MB, Sharma S, Surmeier DJ, Eberwine JH, Chesselet MF. Multiplicity of glutamate receptor subunits in single striatal neurons: an RNA amplification study. Mol Pharmacol. 1996;49:852-859.
75. Hemby SE, Ginsberg SD, Brunk B, Arnold SE, Trojanowski JQ, Eberwine JH. Gene expression profile for schizophrenia: discrete neuron transcription patterns in the entorhinal cortex. Arch Gen Psychiatry. 2002;59:631-640.
76. O'Dell DM, Raghupathi R, Crino PB, Eberwine JH, McIntosh TK. Traumatic brain injury alters the molecular fingerprint of TUNEL-positive cortical neurons In vivo: A single-cell analysis. J Neurosci. 2000;20:4821-4828.
77. Crino PB, Trojanowski JQ, Dichter MA, Eberwine J. Embryonic neuronal markers in tuberous sclerosis: single-cell molecular pathology. Proc Natl Acad Sci U S A. 1996;93:14152-14157.